WASHINGTON, D.C. – AdvaMed today sent the following letter to Health and Human Services (HHS) Secretary Azar requesting that he extend the declared federal public health emergency (PHE) beyond its current expiration date, so that the medical technology industry can continue to efficiently deliver the tools hospitals need to treat people with COVID-19. In light of recent reports that the PHE would likely be extended, AdvaMed president and CEO Scott Whitaker requested that the medical technology industry be given the opportunity to weigh in on any future decision to terminate the PHE.
Press Release | July 1, 2020
Press Release | June 30, 2020
WASHINGTON, D.C. - Today, 340 organizations signed a letter urging Congressional leaders to make telehealth flexibilities created during the COVID-19 pandemic permanent. Those signing this multi-stakeholder letter include national and regional organizations representing a full range of health care stakeholders and all 50 states, the District of Columbia, and Puerto Rico.
Press Release | June 23, 2020
WASHINGTON, D.C. – The MedTech Conference, powered by AdvaMed, promises to continue its tradition of providing world-class programming for the medical technology community, announcing today that the conference will be an all-virtual experience for 2020, and that its plan to host the conference in Toronto will be pushed to 2022.
July 15, 2020 |
This virtual partnering event is an opportunity for universities to build relationships with the medical technology industry. Our panelists will discuss topics related to intellectual property,... Read More
July 23, 2020 |
High demand for cancer diagnostics tests and sequencing-based cancer assays have made China an important market for IVD manufacturers over the past several years. Join us on Thursday, July 23 at 11 a... Read More
July 28, 2020 |
On July 28, 2020, from 1:00pm-2:00pm ET, QAD and AdvaMed will hold a webinar: The Medical Device Industry Needs Risk Management in the New Normal. The current state of the world has sent many... Read More
July 29, 2020 |
AdvaMed, Amazon Web Services (AWS), and Koch Disruptive Technologies (KDT) have partnered to host a virtual showcase of medtech and digital health startup and scaleup companies with transformational... Read More
Denver, Colo., June 11, 2020 — The Association of periOperative Registered Nurses (AORN) today announced survey results of more than 1000 surgical nurse leaders in the United States regarding how their facilities are managing the resumption of elective surgeries. The survey results are intended to help medical device manufacturers understand their customers’ pace and product needs as ORs ramp up their efforts to return to full surgical volume. With this information, industry can plan their...
Retired USMC Captain, Derek Herrera, to Take Chairman Role for MVPvets, a Nonprofit That Helps Military Veterans Find Careers...
SAN DIEGO, May 27, 2020 /PRNewswire/ -- MVPvets, a 501c(3) nonprofit organization that assists and prepares transitioning military veterans for meaningful employment in life science companies, announced the appointment of new Chairman of its Board of Directors, Capt. Derek Herrera, USMC (Ret.). Herrera has been actively involved as an MVPvets board member since early 2019. He succeeds outgoing Chairman Michael R. Minogue, the Chairman, President and Chief Executive Officer of Abiomed, who has...
BOTHELL, Wash., May 20, 2020 /PRNewswire/ -- FUJIFILM Sonosite, Inc., the world leader in point-of-care ultrasound, has announced Rich Fabian, the company's President and Chief Operating Officer, was appointed to the board of The Advanced Medical Technology Association (AdvaMed), a Washington D.C.-based trade association that leads the effort to advance medical technology in order to achieve healthier lives and healthier economies around the world.
Martinez, CA, USA – March 26, 2020 – Treatment of COVID-19 with ExThera’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has begun in hospitals in Germany and Italy. Seraph 100 treatments of COVID-19 are also expected to begin soon in France and the USA. Seraph 100 is the only ‘hemoperfusion device’ approved for the reduction of pathogens in blood. In recent EU clinical cases improved lung function and rapid reduction of drug-resistant bacterial pathogens occurred with Seraph 100...
HAYWARD, Calif.--RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT)* to treat all stages of cancer today announced it has received marketing clearance from the U.S. Food & Drug Administration (FDA) for stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS) and intensity modulated radiotherapy (IMRT) for its RefleXion™ X1 machine. “We are at the forefront of an enormous change in expanding the use of radiotherapy from a...
July 2, 2020 - 3:47pm
“We’re relying on the federal government to continue supporting our efforts by maintain the current public health e… https://t.co/SkS7TtcdDW